phase 2_completion

BioCanRx — ipilimumab (Phase II Trial Completion)

April 30, 2026ipilimumabupdated 4mo ago

community read0 votes

Therapy area: Oncology. Indication: Kidney Cancer (Renal Cell Cancer), Metastatic Renal Cell Carcinoma

Data sources

globaldata

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?